Stockreport

XTL Biopharmaceuticals receives Nasdaq bid price deficiency notice [Seeking Alpha]

XTL Biopharmaceuticals Ltd. - American Depositary Shares  (XTLB) 
US:NASDAQ Investor Relations: xtlbio.com
PDF The deficiency is based on the company's ADS closing bid price being below $1 for 30 consecutive business days. XTL has a 180-day compliance period, ending June 22, 2 [Read more]